Mucus Distribution Model in a Lung with Cystic Fibrosis
暂无分享,去创建一个
Peter Salamon | Sara Zarei | Ali Mirtar | Forest Rohwer | Douglas J. Conrad | Rebecca J. Theilmann | P. Salamon | F. Rohwer | R. Theilmann | D. Conrad | S. Zarei | A. Mirtar
[1] Federico Marchetti,et al. Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature , 2004, European Journal of Clinical Pharmacology.
[2] Ruy M Ribeiro,et al. Hepatitis B virus kinetics and mathematical modeling. , 2004, Seminars in liver disease.
[3] Douglas W. MacEwan,et al. Roentgenologic Anatomy of the Lung. , 1979 .
[4] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[5] Richard B Buxton,et al. Quantitative MRI measurement of lung density must account for the change in T 2* with lung inflation , 2009, Journal of magnetic resonance imaging : JMRI.
[6] A P Yoganathan,et al. Dynamics of systolic pulmonary venous flow in mitral regurgitation: mathematical modeling of the pulmonary venous system and atrium. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[7] B Suki,et al. Branching design of the bronchial tree based on a diameter-flow relationship. , 1997, Journal of applied physiology.
[8] Maynard Thompson,et al. Mathematical Modeling and Computer Simulation , 2005 .
[9] J. Ardell,et al. Vascular tree structure affects lung blood flow heterogeneity simulated in three dimensions. , 1997, Journal of applied physiology.
[10] Avner Friedman,et al. Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers , 2010, Theoretical Biology and Medical Modelling.
[11] Alissa M. Weaver,et al. Mathematical modeling of cancer: the future of prognosis and treatment. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[12] J L Hankinson,et al. Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.
[13] H. Fuchs,et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. , 1994, The New England journal of medicine.